Meghraj Suryawanshi | Pharmacology and Pharmaceutical Science | Best Researcher Award

Published on by World Top Scientists

Prof. Dr. Meghraj Suryawanshi | Pharmacology and Pharmaceutical Science | Best Researcher Award

Assistant Professor | Sandip Institute of Pharmaceutical Sciences | India

Dr. Meghraj Vivekanand Suryawanshi is an accomplished Associate Professor and Training & Placement Coordinator at the Sandip Institute of Pharmaceutical Sciences, Nashik, specializing in pharmaceutics. He holds a Ph.D. in Pharmaceutics from Jaipur National University, an M.Pharm in Pharmaceutics from R.C. Patel Institute of Pharmaceutical Education and Research, a B.Pharm from Sinhgad Institutes of Pharmaceutical Sciences, and an MBA in Hospital Administration. Dr. Suryawanshi has extensive professional experience, serving as a Ph.D. research scholar, Assistant Professor at multiple institutions, and co-founder and CTO of AllWell Nutritech LLP, where he contributed to start-up incubation and entrepreneurial initiatives. He has supervised numerous undergraduate and postgraduate students and actively coordinated academic and administrative programs including training and placement, entrepreneurship, library management, and examination coordination. His research focuses on advanced drug delivery systems, formulation development, and pharmaceutical technology, with a significant body of publications contributing to national and international journals. Dr. Suryawanshi has also engaged in editorial responsibilities and professional memberships that support scholarly exchange and innovation in the pharmaceutical sciences. Recognized for his dedication to research, education, and mentorship, he has been instrumental in fostering academic excellence, student development, and industry collaboration, demonstrating leadership, scientific rigor, and a commitment to advancing the field of pharmaceutics at both institutional and broader professional levels.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

1. Suryawanshi, I., Srinidhi, S., Singh, S., Kalia, R., Kunchala, R. K., Mudavath, S. L., …. (2021). Downshifting and upconversion dual mode emission from lanthanide doped GdPO4 nanorods for unclonable anti-counterfeiting. Materials Today Communications, 26, 102144.

2. Patil, S. M., Suryawanshi, M. V., Chandanshive, V. V., Kurade, M. B., Govindwar, S. P., …. (2020). Regeneration of textile wastewater deteriorated microbial diversity of soil microcosm through bioaugmentation. Chemical Engineering Journal, 380, 122533.

3. Suryawanshi, M. V., Gujarathi, P. P., Mulla, T., & Bagban, I. (2024). Hypericum perforatum: A comprehensive review on pharmacognosy, preclinical studies, putative molecular mechanism, and clinical studies in neurodegenerative disorders. Naunyn-Schmiedeberg’s Archives of Pharmacology, 397(6), 3803–3818.

4. Bhagat, D. S., Suryawanshi, I. V., Gurnule, W. B., Sawant, S. S., & Chavan, P. B. (2021). Greener synthesis of CuO nanoparticles for enhanced development of latent fingerprints. Materials Today: Proceedings, 36, 747–750.

5. Suryawanshi, I., Kalia, R., Kunchala, R. K., Mudavath, S. L., & Naidu, B. S. (2022). Detection of latent fingerprints using luminescent Gd0.95Eu0.05PO4 nanorods. Journal of Rare Earths, 40(4), 572–578.

Mantosh Kumar Satapathy | Pharmacology | Best Researcher Award

Published on by World Top Scientists

Dr. Mantosh Kumar Satapathy | Pharmacology | Best Researcher Award

Mantosh Kumar Satapathy  | Taipei Medical University | Taiwan

Dr. Mantosh Kumar Satapathy, Ph.D., is a distinguished biomedical scientist, biotechnologist, pharmacologist, and tissue engineer based at Taipei Medical University, Taiwan, with extensive international experience in pharmacology, biomedical engineering, and nanobiotechnology. He earned his Ph.D. in Biomedical Materials and Tissue Engineering from Taipei Medical University, following an M.Tech. in Industrial Biotechnology and a Bachelor of Pharmacy, establishing a strong foundation in translational medical research. Dr. Satapathy has held postdoctoral and research fellow positions at leading institutions, leading projects on advanced nanodrug delivery systems, stem cell therapeutics, tissue engineering, and nanoformulation design, while supervising molecular biology laboratories and mentoring junior researchers. His research contributions include the development of stimuli-responsive nanocomposite hydrogels for orthopedic and skin tissue regeneration, engineering of nanocurcumin-based formulations for targeted therapies, and investigations into gene regulation and drug repurposing in cancer and skin pathologies. He has published extensively in high-impact peer-reviewed journals, contributed to international book chapters, co-invented a U.S. patent, and presented his work at global scientific conferences. Dr. Satapathy’s work has been recognized with multiple Outstanding Postdoctoral Researcher awards, and he actively serves as a peer reviewer, reflecting his leadership in the scientific community. He is a life member of professional organizations, has completed specialized research training in molecular diagnostics and biotechnology, and continues to advance interdisciplinary research that bridges fundamental science and clinical application, demonstrating exceptional impact in biomedical innovation.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

1. Banerjee, P., Satapathy, M., Mukhopahayay, A., & Das, P. (2014). Leaf extract mediated green synthesis of silver nanoparticles from widely available Indian plants: Synthesis, characterization, antimicrobial property and toxicity analysis. Bioresources and Bioprocessing, 1(1), 3.

2. Satapathy, M. K., Yen, T. L., Jan, J. S., Tang, R. D., Wang, J. Y., Taliyan, R., & Yang, C. H. (2021). Solid lipid nanoparticles (SLNs): An advanced drug delivery system targeting brain through BBB. Pharmaceutics, 13(8), 1183.

3. Satapathy, M. K., & Das, P. (2014). Optimization of crystal violet dye removal using novel soil-silver nanocomposite as nanoadsorbent using response surface methodology. Journal of Environmental Chemical Engineering, 2(1), 708–714.

4. Satapathy, M. K., Banerjee, P., & Das, P. (2015). Plant-mediated synthesis of silver-nanocomposite as novel effective azo dye adsorbent. Applied Nanoscience, 5(1), 1–9.

5. Satapathy, M. K., Nyambat, B., Chiang, C. W., Chen, C. H., Wong, P. C., Ho, P. H., … (2018). A gelatin hydrogel-containing nano-organic PEI–Ppy with a photothermal responsive effect for tissue engineering applications. Molecules, 23(6), 1256.

Ksenia Blinova | Pharmacology | Best Researcher Award

Published on by World Top Scientists

Dr. Ksenia Blinova | Pharmacology | Best Researcher Award

Associate Director at US Food and Drug Administration, United States

Dr. Ksenia Blinova, Ph.D., is the Associate Director for the Division of Applied Regulatory Science at the U.S. Food and Drug Administration, where she leads innovative research, regulatory reviews, and scientific consultations that advance translational science in support of public health. With a strong academic foundation in physics, mathematics, and cardiac electrophysiology, she has built a distinguished career focused on bridging fundamental science with regulatory applications. Since joining the FDA as a Commissioner’s Fellow, Dr. Blinova has held key leadership roles, including Deputy Director of the Division of Biomedical Physics, where she led multidisciplinary teams in developing over forty regulatory science tools that improved the evaluation of medical devices across fields such as cardiology, neurostimulation, diagnostics, and patient monitoring. Her career reflects a unique combination of scientific excellence, leadership, and commitment to advancing safe and effective medical products, making her an influential figure in the field of regulatory science.

Professional Profile 

Scopus Profile | ORCID Profile 

Education

Dr. Ksenia Blinova earned her undergraduate and doctoral degrees in Physics and Mathematics from Moscow State University, where she developed a strong foundation in quantitative sciences and analytical problem-solving. She further advanced her academic journey through a postdoctoral fellowship at the National Heart, Lung, and Blood Institute at the National Institutes of Health. Her research during this period centered on cardiac electrophysiology and metabolism, areas that deepened her expertise in biomedical applications of physical sciences. This educational trajectory not only equipped her with advanced technical knowledge but also gave her a unique interdisciplinary perspective that integrates rigorous physics and mathematical methodologies with life sciences and clinical research. Her educational background has been pivotal in shaping her ability to address complex regulatory and scientific challenges, contributing to her capacity for innovation and leadership in translational science and regulatory policy at the intersection of medicine, technology, and public health.

Experience

Dr. Blinova has built a distinguished career at the U.S. Food and Drug Administration, beginning as a Commissioner’s Fellow and progressing to influential leadership roles. As Deputy Director of the Division of Biomedical Physics in the Center for Devices and Radiological Health, she guided a multidisciplinary team in creating innovative regulatory science tools that addressed critical challenges in medical device safety and effectiveness. Her leadership was instrumental in developing methods and resources for fields such as cardiology, neurostimulation, ophthalmology, in-vivo diagnostics, and advanced patient monitoring. Currently serving as Associate Director for the Division of Applied Regulatory Science in the Office of Clinical Pharmacology, she oversees research, scientific consultations, and regulatory reviews that support the FDA’s translational science priorities. Through these roles, she has combined her technical expertise with strategic vision, ensuring that scientific advancements translate into practical regulatory applications that safeguard patient health and promote medical innovation.

Research Focus

Dr. Blinova’s research focuses on advancing translational and regulatory science to accelerate the safe and effective delivery of medical products to patients. Her early work in cardiac electrophysiology and metabolism provided insights into fundamental mechanisms of heart function, laying the groundwork for her later contributions in biomedical physics and device evaluation. At the FDA, she has led research efforts that integrate computational modeling, experimental studies, and regulatory tool development to address complex safety and efficacy challenges in medical devices and drug-device combinations. Her team has developed innovative approaches to evaluate technologies in cardiology, neurostimulation, electrical safety, diagnostics, and patient monitoring, ensuring that regulatory science keeps pace with rapid technological advances. By bridging basic science, applied research, and policy, her work exemplifies the role of regulatory science in translating innovation into tangible benefits for patients and healthcare systems, while maintaining a focus on safety, effectiveness, and public health impact.

Award and Honor

Throughout her career, Dr. Blinova has been recognized for her leadership, innovation, and contributions to regulatory science. Her accomplishments include guiding the development of over forty regulatory tools that have had a lasting impact on how medical devices are assessed for safety and effectiveness. These achievements reflect not only her scientific expertise but also her ability to collaborate across disciplines to solve pressing healthcare challenges. Her recognition within the FDA and broader scientific community underscores her role as a leader who consistently advances the field of translational science. Honors and awards in her career highlight her success in bridging science and regulation, her dedication to patient safety, and her influence in shaping modern approaches to medical product evaluation. These distinctions serve as a testament to her sustained contributions, her commitment to innovation, and her growing impact as a respected figure in regulatory and biomedical research.

Publication Top Notes

  • Title: Nonclinical Human Cardiac New Approach Methodologies (NAMs) Predict Vanoxerine-Induced Proarrhythmic Potential
    Authors: M. Iveth Garcia, Bhavya Bhardwaj, Keri Dame, Verena Charwat, Brian A. Siemons, Ishan Goswami, Omnia A. Ismaiel, Sabyasachy Mistry, Tromondae K. Feaster, Kevin E. Healy, et al.
    Year: 2025

  • Title: In Vitro Assay Development to Study Pulse Field Ablation Outcome Using Solanum Tuberosum
    Authors: Akshay Narkar, Abouzar Kaboudian, Yasaman Ardeshirpour, Maura Casciola, Tromondae Feaster, Ksenia Blinova
    Year: 2024
    Citations: 2

  • Title: Nonclinical evaluation of chronic cardiac contractility modulation on 3D human engineered cardiac tissues
    Authors: Tromondae K. Feaster, Jourdan K. Ewoldt, Anna Avila, Maura Casciola, Akshay Narkar, Christopher S. Chen, Ksenia Blinova
    Year: 2024

  • Title: Comprehensive Collection of Current Methods for Contractility and Electrophysiology Recordings in Human Cardiac Cells
    Authors: Ksenia Blinova, J. Pierson, A. Narkar
    Year: 2023

  • Title: Human in vitro assay for irreversible electroporation cardiac ablation
    Authors: Maura Casciola, Tromondae K. Feaster, M. J. Caiola, D. Keck, Ksenia Blinova
    Year: 2023

  • Title: Acute effects of cardiac contractility modulation stimulation in conventional 2D and 3D human induced pluripotent stem cell-derived cardiomyocyte models
    Authors: Tromondae K. Feaster, N. Feric, I. Pallotta, A. Narkar, M. Casciola, M. P. Graziano, R. Aschar-Sobbi, Ksenia Blinova
    Year: 2022

  • Title: Evaluation of Cardiac Contractility Modulation Therapy in 2D Human Stem Cell-Derived Cardiomyocytes
    Authors: Tromondae K. Feaster, Maura Casciola, Akshay Narkar, Ksenia Blinova
    Year: 2022

  • Title: Human in vitro neurocardiac coculture (iv NCC) assay development for evaluating cardiac contractility modulation
    Authors: Akshay Narkar, Tromondae K. Feaster, Maura Casciola, Ksenia Blinova
    Year: 2022

  • Title: Human cardiomyocytes are more susceptible to irreversible electroporation by pulsed electric field than human esophageal cells
    Authors: Maura Casciola, Devin Keck, Tromondae K. Feaster, Ksenia Blinova
    Year: 2022

  • Title: Chronic Cardiotoxicity Assays Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPSC-CMs)
    Authors: Akshay Narkar, James M. Willard, Ksenia Blinova
    Year: 2022

  • Title: Cardiovascular medical devices: Regulatory science research overview in the office of science and engineering laboratories (OSEL) at the food and drug administration (FDA)
    Authors: K. Aycock, Ksenia Blinova, M. Casciola, B. Craven, M. Di Prima, G. D’Souza, N. Duraiswamy, M. Farahmand, P. Hariharan, L. Herbertson, et al.
    Year: 2021

  • Title: Acute effects of cardiac contractility modulation on human induced pluripotent stem cell–derived cardiomyocytes
    Authors: Tromondae K. Feaster, Maura Casciola, Akshay Narkar, Ksenia Blinova
    Year: 2021

Conclusion

Dr. Ksenia Blinova has demonstrated exceptional expertise and leadership in translational and regulatory science, particularly in the evaluation and development of cardiac therapies and medical devices. Her extensive body of research, including numerous high-impact publications on human in vitro cardiac models, contractility modulation, and electroporation assays, reflects a consistent focus on innovative approaches that bridge fundamental science with practical clinical and regulatory applications. She has led multidisciplinary teams to develop tools and methodologies that enhance patient safety, accelerate medical innovation, and provide reliable scientific evidence for regulatory decisions. Her work not only advances the understanding of cardiac electrophysiology and device performance but also sets new standards for predictive, nonclinical cardiac research. Overall, Dr. Blinova’s contributions exemplify the qualities of a pioneering researcher whose scientific rigor, leadership, and commitment to public health make her highly deserving of recognition in any Best Researcher Award.

Dr. Anca-Roxana Petrovici | Pharmacology | Best Researcher Award

Published on by World Top Scientists

Dr. Anca-Roxana Petrovici | Pharmacology | Best Researcher Award

Dr. Anca-Roxana Petrovici, “Petru Poni” Institute of Macromolecular Chemistry, Romania

Dr. Anca-Roxana Petrovici is a prominent researcher at the “Petru Poni” Institute of Macromolecular Chemistry in Romania. With a strong focus on macromolecular science, she has made significant contributions to the field through her innovative research and publications, aiming to advance knowledge and applications in polymer chemistry.

Profile

Scopus

Orcid

Education 🎓

Dr. Petrovici obtained her Ph.D. in Macromolecular Chemistry, where her thesis focused on the synthesis and characterization of novel polymer materials. Her academic journey has been marked by a commitment to excellence and a passion for advancing the field of polymer science.

Experience 💼

With extensive experience at the “Petru Poni” Institute, Dr. Petrovici has engaged in various research projects and collaborations, contributing to the development of new materials and applications. Her role has also involved mentoring students and collaborating with industry partners to apply scientific findings practically.

Research Interest 🔬

Dr. Petrovici’s research interests lie primarily in the synthesis, characterization, and application of macromolecular materials. She focuses on the development of innovative polymers with specific functionalities, exploring their potential in diverse fields such as biomedicine, packaging, and nanotechnology.

Awards 🏆

Throughout her career, Dr. Petrovici has received numerous accolades recognizing her contributions to polymer chemistry. While specific awards are not listed here, her work has been widely cited, reflecting her influence in the scientific community.

Publication Top notes 📚

Correction: Simionescu et al. The Multifaceted Role of Extracellular Vesicles in Glioblastoma: microRNA Nanocarriers for Disease Progression and Gene Therapy. Pharmaceutics 2021, 13, 988

Phenolic Composition and Bioactivities of Invasive Ailanthus altissima (Mill.) Swingle Leaf Extracts Obtained by Two-Step Sequential Extraction

In Vitro Screening of Ecotoxic and Cytotoxic Activities of Ailanthus altissima Leaf Extract against Target and Non-Target Plant and Animal Cells

Enhancing the Antioxidant Potential of Weissella confusa PP29 Probiotic Media through Incorporation of Hibiscus sabdariffa L. Anthocyanin Extract

Complexes of Ibuprofen Thiazolidin-4-One Derivatives with β-Cyclodextrin: Characterization and In Vivo Release Profile and Biological Evaluation

NEW METAL COMPLEXES WITH ARIL-ACETIC STRUCTURE: PREPARATION, CHARACTERIZATION, AND IN VITRO ANTIINFLAMMATORY EFFECTS

Dextran-Chitosan Composites: Antioxidant and Anti-Inflammatory Properties

3D Matrices for Enhanced Encapsulation and Controlled Release of Anti-Inflammatory Bioactive Compounds in Wound Healing

Dextran Formulations as Effective Delivery Systems of Therapeutic Agents

Probiotic Properties of Weissella confusa PP29 on Hibiscus sabdariffa L. Media

Samer Younes | Pharmacology | Best Researcher Award

Published on by World Top Scientists

Dr. Samer Younes | Pharmacology | Best Researcher Award

Department of Pharmacy, Tartous University, Syria

🌟 Samer Younes is a dedicated and forward-thinking pharmacy graduate from Tartous University, Syria. With a strong academic background and diverse experience in both practical pharmacy and research, Samer is committed to continuous learning and professional development. His work ethic is demonstrated through his active participation in community volunteering, internships, and a keen interest in expanding his expertise in the field of pharmacy and nutrition.

Profile

Google Scholar

Research for “Best Researcher Award”

Strengths for the Award

1. Strong Academic Foundation and Practical Experience:
Samer Younes has demonstrated a solid academic foundation with a Bachelor’s degree in Pharmacy from Tartous University, complemented by practical experience in various pharmacy roles and internships. His work as a pharmacist involved crucial tasks such as prescription processing and handling patient queries, showcasing his applied knowledge in the field.

2. Commitment to Continuous Learning and Professional Development:
Samer’s commitment to professional growth is evident from his various certifications, including Quality Advisor and specialized training in Nutrition and Laboratory Work. These certifications not only add to his qualifications but also highlight his proactive approach to expanding his skill set and knowledge.

3. Volunteer Experience and Community Engagement:
His volunteer work with UNICEF and involvement in the Campaign against Covid-19 underline his dedication to societal well-being and public health. His role in these initiatives, including vaccinations and monitoring children’s rights, demonstrates his ability to apply his expertise in real-world scenarios and contribute to community health.

4. Language and Digital Skills:
Samer possesses proficiency in multiple languages, which enhances his ability to communicate and collaborate in diverse settings. His digital skills, including expertise in Microsoft Office and analytical tools, are essential for modern research and data analysis.

5. Strong Recommendations:
Samer has received commendations from reputable professors, such as Wissam Zam and Zeina Hamama, who can vouch for his academic prowess and research capabilities. Their recommendations add credibility to his achievements and potential as a researcher.

Areas for Improvement

1. Limited Research Publications:
While Samer has a commendable academic background and practical experience, his publication record appears limited. Expanding his research output and publishing in high-impact journals could enhance his visibility and influence in the field of pharmacy and research.

2. Focused Research Experience:
Although Samer has engaged in diverse roles and projects, a more focused research experience in specific areas of pharmacy or a related field could strengthen his application. Specializing in a niche area and contributing significant research could further solidify his candidacy for the award.

3. Networking and Collaboration:
Building a stronger professional network and engaging in collaborative research projects could provide additional opportunities for growth and recognition. Participating in conferences and research forums would also help him gain further exposure and feedback from the scientific community.

4. Enhanced Research Visibility:
Increasing his presence in research communities, such as ResearchGate and Google Scholar, by regularly updating his profiles and engaging with other researchers could improve his visibility and impact in the research domain.

Education

🎓 Bachelor Degree in Pharmacy
Department of Pharmacy, Tartous University
(01/09/2018 – 31/01/2024)
Samer graduated with a final grade of 72.2/100, having gained a solid foundation in pharmaceutical sciences and practical experience through his coursework and projects.

Experience

💊 Pharmacist
Ghadeer Pharmacy
(01/12/2020 – 19/08/2022)
Samer managed prescription processing, handled patient queries, ensured compliance with pharmacy regulations, and updated inventory information, showcasing his practical expertise in the pharmaceutical field.

🔬 Internship: Campaign Against Covid-19
(12/09/2020 – 12/05/2021)
In this role, Samer contributed to examinations and vaccinations, playing a crucial part in the fight against the pandemic.

🌍 Volunteering: UNICEF
(18/11/2013 – 20/11/2013)
Samer’s work with UNICEF included training and voluntary activities, reflecting his commitment to global health and community support.

Research Interests

Samer’s research interests lie in the intersection of nutrition and pharmacology, particularly focusing on the impact of micronutrients on health conditions and treatment outcomes. His work aims to advance understanding in these areas and contribute to more effective therapeutic strategies.

Awards and Certifications

  • Quality Advisor – Insight (Training Development & Consulting) (24/11/2022 – 28/11/2022)
  • Laboratory Work Level 1+2 – Insight (24/11/2022 – 28/11/2022)
  • Nutrition and Diets – Insight (02/02/2022 – 20/02/2022)
  • Nutrition Basics – Insight (12/12/2021 – 20/12/2021)

Publications Top Notes

  1. The Role of Nutrition on the Treatment of Covid-19
    Human Nutrition & Metabolism, 200255 (2024)
    Cited by: 4
  2. The Role of Micronutrients on the Treatment of Diabetes
    Human Nutrition & Metabolism, 200238 (2024)
    Cited by: 4
  3. The Impact of Micronutrients on the Sense of Taste
    Human Nutrition & Metabolism, 200231 (2023)
    Cited by: 2
  4. The Relationship Between Gender and Pharmacology
    Current Research in Pharmacology and Drug Discovery, 100192 (2024)
    Cited by: 1

Conclusion

Samer Younes exhibits many strengths that align well with the criteria for the “Best Researcher Award.” His academic qualifications, practical experience, and dedication to continuous learning and community service are commendable. To strengthen his candidacy, focusing on increasing his research publications, specializing in a specific area, and enhancing his professional network and visibility will be crucial. With his solid foundation and commitment to growth, Samer has the potential to make significant contributions to the field and be a strong contender for the award.